These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 8275492

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prostate-specific antigen promoter driven gene therapy targeting DNA polymerase-alpha and topoisomerase II alpha in prostate cancer.
    Lee CH, Liu M, Sie KL, Lee MS.
    Anticancer Res; 1996; 16(4A):1805-11. PubMed ID: 8712704
    [Abstract] [Full Text] [Related]

  • 24. Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast, and bladder cancers.
    An G, Ng AY, Meka CS, Luo G, Bright SP, Cazares L, Wright GL, Veltri RW.
    Cancer Res; 2000 Dec 15; 60(24):7014-20. PubMed ID: 11156405
    [Abstract] [Full Text] [Related]

  • 25. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M, Drullinsky P, Guillem J, Moore MA.
    Clin Cancer Res; 1997 Nov 15; 3(11):1931-41. PubMed ID: 9815582
    [Abstract] [Full Text] [Related]

  • 26. Elevated expression of the ornithine decarboxylase gene in human esophageal cancer.
    Yoshida M, Hayashi H, Taira M, Isono K.
    Cancer Res; 1992 Dec 01; 52(23):6671-5. PubMed ID: 1423312
    [Abstract] [Full Text] [Related]

  • 27. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay.
    Guadagni F, Roselli M, Cosimelli M, Spila A, Cavaliere F, Tedesco M, Arcuri R, Abbolito MR, Casale V, Pericoli MN, Vecchione A, Casciani CU, Greiner JW, Schlom J.
    Cancer Res; 1996 Nov 15; 56(22):5293-8. PubMed ID: 8912871
    [Abstract] [Full Text] [Related]

  • 28. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas.
    Weber MM, Fottner C, Liu SB, Jung MC, Engelhardt D, Baretton GB.
    Cancer; 2002 Nov 15; 95(10):2086-95. PubMed ID: 12412161
    [Abstract] [Full Text] [Related]

  • 29. Preliminary studies on the isolation and characterization of predominant prostatic proteins.
    Lombardo ME, Meyer-Siegler K, Hakky SI, Hudson PB.
    Prostate; 1996 Dec 15; 29(6):381-5. PubMed ID: 8977635
    [Abstract] [Full Text] [Related]

  • 30. The activity of topoisomerases is related to the grade and stage in human renal cell carcinoma.
    Shuin T, Sano K.
    Anticancer Res; 1994 Dec 15; 14(6B):2621-6. PubMed ID: 7872691
    [Abstract] [Full Text] [Related]

  • 31. Novel mutation of topoisomerase I in rendering cells resistant to camptothecin.
    Chang JY, Liu JF, Juang SH, Liu TW, Chen LT.
    Cancer Res; 2002 Jul 01; 62(13):3716-21. PubMed ID: 12097280
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis.
    Jenkins PJ, Khalaf S, Ogunkolade W, McCarthy K, David T, Hands RE, Davies D, Bustin SA.
    Endocr Relat Cancer; 2005 Dec 01; 12(4):891-901. PubMed ID: 16322329
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.
    Grandis JR, Tweardy DJ.
    Cancer Res; 1993 Aug 01; 53(15):3579-84. PubMed ID: 8339264
    [Abstract] [Full Text] [Related]

  • 36. Transfected neu oncogene induces human prostate cancer metastasis.
    Zhau HY, Zhou J, Symmans WF, Chen BQ, Chang SM, Sikes RA, Chung LW.
    Prostate; 1996 Feb 01; 28(2):73-83. PubMed ID: 8604395
    [Abstract] [Full Text] [Related]

  • 37. Down-regulation of PLK3 gene expression by types and amount of dietary fat in rat colon tumors.
    Dai W, Liu T, Wang Q, Rao CV, Reddy BS.
    Int J Oncol; 2002 Jan 01; 20(1):121-6. PubMed ID: 11743651
    [Abstract] [Full Text] [Related]

  • 38. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
    Sehested M, Wessel I, Jensen LH, Holm B, Oliveri RS, Kenwrick S, Creighton AM, Nitiss JL, Jensen PB.
    Cancer Res; 1998 Apr 01; 58(7):1460-8. PubMed ID: 9537249
    [Abstract] [Full Text] [Related]

  • 39. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.
    Kakehi Y, Wu WJ, Kim WJ, Arao S, Fukumoto M, Yoshida O.
    Int J Urol; 1995 Nov 01; 2(5):309-15. PubMed ID: 8749949
    [Abstract] [Full Text] [Related]

  • 40. Overexpression of human topoisomerase I in baby hamster kidney cells: hypersensitivity of clonal isolates to camptothecin.
    Madden KR, Champoux JJ.
    Cancer Res; 1992 Feb 01; 52(3):525-32. PubMed ID: 1310066
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.